CLINICAL_TRIALS
trial_result
· 2021-07-02
Clinical Trial Update: Dysport in Hallux Abducto Valgus (HAV) Phase IIa [Phase 2]
Summary
Phase IIa clinical trial of Dysport for hallux abductovarus (hallux valgus) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Hallux Abducto Valgus | Phase 2 | Status: COMPLETED | Results posted: 2021-07-02